Clinical Trials
35 trialsEVEREST-2
A2 Biotherapeutics Inc.
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
Fudan University
CrEATE
UMC Utrecht
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med LLC
FUDOSE
UNICANCER
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
MIMICC
Fondazione del Piemonte per l'Oncologia
Autologous CAR-T Cells Targeting B7-H3 in PDAC
UNC Lineberger Comprehensive Cancer Center
AB02
AstraZeneca
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Memorial Sloan Kettering Cancer Center
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Daiichi Sankyo
SHARON
General Oncology, Inc.
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
Northern Jiangsu People's Hospital
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
Northern Jiangsu People's Hospital
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
University Health Network, Toronto
ENLIGHT
City of Hope Medical Center
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Fudan University
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
Tongji Hospital
SPTP
Fudan University
CCGLC-015
Tongji Hospital
CCGLC-016
Tongji Hospital
Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC
Sun Yat-sen University
LOGICAN
UNICANCER
PVMRD
Peking University Shougang Hospital
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
Sun Yat-sen University
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
The Affiliated Hospital of Xuzhou Medical University
COLLISION RELAPSE Trial
Amsterdam UMC, location VUmc
RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection
E-DA Hospital
Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates
University of Liege
HepatoPredict
Centro Hospitalar de Lisboa Central
Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)
National Cancer Center, Korea
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
ChineseAMS